1 year return (CAGR)
710.92%
Cidara Therapeutics Inc Exchange (NASDAQ, USD)
CDTX
-
+0.06 (+0.03%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
144.76%
5 year return (CAGR)
40.80%
10 year return (CAGR)
-3.92%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
6.96B
Price/Sales
-
Ent value
6.76B
Price/Book
16.48
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-1.09%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 221.32 |
| Daily high | 221.41 |
| Daily low | 221.25 |
| Daily Volume | 2.69M |
| 1y analyst estimate | 221.50 |
| Beta | 1.46 |
| EPS (TTM) | -11.88 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CDTX | S&P500 | |
| Current price drop from All-time high | -35.87% | -1.04% |
| Highest price drop | -97.52% | -56.47% |
| Date of highest drop | 13 May 2022 | 9 Mar 2009 |
| Avg drop from high | -73.88% | -10.68% |
| Avg time to new high | 338 days | 12 days |
| Max time to new high | 2519 days | 1805 days |
News
No items found